Clene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.About CLNN
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.
CEORobert Dee Etherington
CEORobert Dee Etherington
Employees76
Employees76
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees76
Employees76
CLNN Key Statistics
Market cap33.97M
Market cap33.97M
Price-Earnings ratio-1.30
Price-Earnings ratio-1.30
Dividend yield—
Dividend yield—
Average volume39.65K
Average volume39.65K
High today$3.80
High today$3.80
Low today$3.64
Low today$3.64
Open price$3.72
Open price$3.72
Volume32.69K
Volume32.69K
52 Week high$6.96
52 Week high$6.96
52 Week low$2.28
52 Week low$2.28
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CLNN. This list is generated using Robinhood data, and it’s not a recommendation.